Atlas Trials

Safety and Immunogenicity Study of BCG, H4:IC31, and H56:IC31 Revaccination in Healthy Adolescents

Clinical trial NCT02378207 · COMPLETED

Trial details

NCT number
NCT02378207
Sponsor
Aeras
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Tuberculosis
Start date
2015-05-01
Primary completion
2016-10-31
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.